memantine


Also found in: Medical, Wikipedia.

me·man·tine

 (mə-măn′tēn)
n.
A drug, C20H24N5O4, used in its hydrochloride form to treat symptoms of Alzheimer's disease by inhibiting NMDA receptors.

[me(thyl) + (ada)mant(ane), molecule with a diamond-like structure (from Greek adamās, adamant-, diamond; see adamant) + -ine.]
Translations

memantine

n memantina
References in periodicals archive ?
Amneal Pharmaceuticals has launched memantine hydrochloride extended-release capsules, the company's AB-rated equivalent for Namenda, in 7 mg, 14 mg, 21 mg and 28 mg strengths.
The researchers looked at evidence from 142 clinical trials of four common cognitive enhancers--donepezil, rivastigmine (Exelon[R]), galantamine (Razedyne[R]) and memantine (Namenda[R]).
M2 PHARMA-July 12, 2017-Zydus Cadila granted final FDA approval to commercialise Memantine Hydrochloride
M2 EQUITYBITES-July 12, 2017-Zydus Cadila granted final FDA approval to commercialise Memantine Hydrochloride
In December 2014, the FDA approved a combination pill for moderate to severe Alzheimers called Namzaric that combines memantine hydrochloride extended-release (Namenda) and donepezil hydrochloride (Aricept).
NAMZARIC is a once-daily, fixed-dose combination of memantine hydrochloride (a NMDA receptor antagonist) and donepezil hydrochloride (an acetylcholinesterase inhibitor, AChEI) for the treatment of moderate to severe Alzheimer's Disease in patients stabilized on 10 mg of donepezil hydrochloride once daily.
Barbara Olivan-Blazquez of the University of Zaragoza, Spain, and colleagues evaluated the efficacy of memantine for pain symptom control in fibromyalgia (Pain.
Memantine blocks glutamate, and glutamate may be a player in perpetuating the pain cycle for patients with fibromyalgia.
Reddy's announced last month its launch of memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of Namenda (memantine HC1) tablets in the United States.
NEW ORLEANS -- The combination of memantine and a cholinesterase inhibitor improved behavioral symptoms in patients with moderate-severe Alzheimer's dementia, according to two pooled, post hoc analyses.
University School of Medicine demonstrates that an Alzheimer's drug called memantine may reduce the impulse to binge eat by acting on an area of brain associated with addictive behavior.
Memantine slows down dementia by reducing the amount of a brain chemical called glutamate.